WHO ICTRP trial
The INTENSIFY Trial: The Effect of a Six-Week Intensified Pharmacological…
ACTRN12625000327482 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12625000327482 |
|---|---|
| Public title | The INTENSIFY Trial: The Effect of a Six-Week Intensified Pharmacological Treatment (Third-Line Medication) for Schizophrenia Compared to Treatment as Usual (Second-Line Medication) in Participants Who Did Not Respond to a First-Line Medication Treatment. |
| Scientific title | Randomised, Controlled Trial to Investigate the Effect of a six-week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Participants Who Had a First-time Treatment Failure on Their First-line Treatment for -Schizophrenia Cohort. |
| Primary sponsor | Lyell McEwin Hospital |
| Secondary sponsors | The University of Adelaide |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | Schizophrenia; Schizophrenia;Mental Health - Schizophrenia |
| Interventions | This is a phase IV multicentre controlled, randomised open label trial for Schizophrenia Participants are randomised to either Treatment as usual (TAU) or Early Intensified Pharmacological Treatment (EIPT) Treatment as Usual (TAU): Switch… |
| Registration date | Apr 17, 2025 |
| Target size | 150 |
| Secondary IDs | Nil Known |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: